APCR Issues Statement on COVID-19

Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

Variety Of Impacts COVID-19 Poses For Biopharma Reflected In Earnings Calls

Thu, 03/19/2020 - 2:08pm

Several firms reporting quarterly earnings this week discussed how the outbreak is affecting supply chains, drug launches and clinical trials.

      Related Stories 

Pfizer’s Abrocitinib Quick Off The Mark In Atopic Dermatitis

Thu, 03/19/2020 - 9:37am

Pfizer’s next-generation JAK1 inhibitor, abrocitinib, continues to show beneficial effects in atopic dermatitis (eczema), in the JADE COMPARE study, comparable...

      Related Stories 

Sage Plans New Trials And Approval Timeline For Zuranolone

Wed, 03/18/2020 - 12:51pm

Sage will initiate three new trials to support FDA approval of the drug for post-partum depression and major depressive disorder...

      Related Stories 

Positive Evidence Stacks Up For Takeda's Dengue Vaccine

Tue, 03/17/2020 - 11:00pm

New long-term clinical data with Takeda’s dengue vaccine contender show a durable response against all four serotypes and support the...

      Related Stories